Clave
Venture capital · Pamplona, Spain · Europe
Clave is a venture capital manager with 20 years of experience that has made more than 90 investments and works actively with portfolio companies on strategy and management. It currently manages 90 million euros and is launching a new 80 million euro fund.
Invests inHealthcare & BiotechFood & Agriculture
In its own wordshealthtechmedtechehealthbiotechnutritionindustrial
Your fit with Clave
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsClave lists 6 checked portfolio companies on its own site and is named in 6 funding rounds, 1 of them as lead. Its most frequent entry is Seed, 60% of the companies with a known first round. Its largest themes are Healthcare & Biotech (67%) and Food & Agriculture (33%). 100% of its companies are based in Spain. It invests most often alongside EONIQ, AMR Action Fund and General Inception.
Counts come from funding rounds that name Clave, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Entry stage
share of companies by the stage of its first roundClave does not state its stages on its site, so only what it does is shown.
Show as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 60% |
| Series A | 40% |
| Series B | 0% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 1 | 0 |
| '26 | 5 | 1 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 8th | 6 companies |
| Recent activity | 86th | 5 rounds in 12 months |
| Early stage | 76th | 60% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 91th | 67% in its largest sector |
| Reach | 20th | 1 country |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| EONIQ | 2 |
| AMR Action Fund | 1 |
| General Inception | 1 |
| Namarel Ventures | 1 |
| Noso Capital | 1 |
| Prous Institute for Biomedical Research | 1 |
| Ship2B Ventures | 1 |
| Sodena | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers6100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 67% | 15% |
| Food & Agriculture | 33% | 3% |
Co-investor network
who it backs companies with, and who they back togetherCompare Clave head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Funds
as stated on its siteRecent portfolio activity
when companies last raised with Clave| Date | Company | Stage |
|---|---|---|
| 19 Oct 2026 | Seed | |
| 10 Sept 2026 | Seed Led | |
| 17 Jul 2026 | Seed | |
| 1 Jul 2026 | Series A | |
| 18 Feb 2026 | Round | |
| 13 Jun 2025 | Series A |
Round details for Clave
Amounts, full round histories and every co-investor in Clave's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
6 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Jun 2025Series A | Funding round | |||
| Connecta Therapeutics is committed to discovering and developing new treatments to respond to unmet CNS medical needs | Healthcare & Biotech | Sept 2026Seed | Funding round | |
| Pharmacelera develops proprietary Computer-Aided Drug Design software based on accurate Quantum-Mechanics algorithms, Machine Learning and High-Performance Computing | Healthcare & Biotech | Feb 2026Round | Funding round | |
| Remolonas offers a subscription service for imperfect fruits and vegetables, as well as other food products from local producers and brands. | Food & Agriculture | Oct 2026Seed | Funding round | |
| Sensesbit helps R&D, quality and sensory teams design studies, organize panels and samples, collect responses, review results and turn sensory evidence into decisions. | Food & AgricultureHealthcare & Biotech | Jul 2026Seed | Funding round | |
| Telum Therapeutics is a global drug discovery biotechnology company specializing in the use of Engineered Phage Lytic Proteins as new antimicrobial products. | Healthcare & Biotech | Jul 2026Series A | Funding round |
About this data
site last read 12 Nov 2026- Site
- clave.capital
- Last read
- 12 Nov 2026
- Watching since
- 6 Nov 2026
- Rounds since
- 13 Jun 2025
- Companies checked
- 6
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Clave's profile as data
Pull Clave's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/clave.capital
# also
GET /v1/firms/clave.capital/portfolio
GET /v1/firms/clave.capital/coinvestors
GET /v1/firms/clave.capital/news